Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Switching Rates of Atogepant Are Lower than CGRP Monoclonal Antibodies (mAbs) in Patients with Migraine Using Claims Database

Education on Preventative Migraine Therapy Impacts Real-world Treatment Selection